Patents by Inventor Barbara Cherry

Barbara Cherry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240032537
    Abstract: Phytoprotective compositions comprising one or more polypeptides having proteolytic activity in an agriculturally acceptable carrier, as well as methods of preparing such compositions and methods of using such compositions for preventing and/or treating phytopathogenic pests to reduce damage in plant propagation materials, plants and plant parts and increase crop yields.
    Type: Application
    Filed: October 9, 2023
    Publication date: February 1, 2024
    Applicant: NOVOZYMES BIOAG A/S
    Inventors: Sharon Inch, Tine Hoff, Michael Frodyma, Michelle Maranta, Barbara Cherry
  • Patent number: 11812747
    Abstract: A method of controlling or preventing pathogenic damage and/or pest damage in a plant propagation material, a plant, part of a plant and/or plant organ, comprising applying on the plant, part of the plant, plant organ, plant propagation material or a surrounding area thereof a phytoprotective agent comprising a protease.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: November 14, 2023
    Assignee: NOVOZYMES BIOAG A/S
    Inventors: Sharon Inch, Tine Hoff, Michael Frodyma, Michelle Maranta, Barbara Cherry
  • Publication number: 20210106013
    Abstract: A method of controlling or preventing pathogenic damage and/or pest damage in a plant propagation material, a plant, part of a plant and/or plant organ, comprising applying on the plant, part of the plant, plant organ, plant propagation material or a surrounding area thereof a phytoprotective agent comprising a protease.
    Type: Application
    Filed: February 6, 2019
    Publication date: April 15, 2021
    Applicant: NOVOZYMES BIOAG A/S
    Inventors: Sharon Inch, Tine Hoff, Michael Frodyma, Michelle Maranta, Barbara Cherry
  • Patent number: 10464973
    Abstract: Disclosed are WapA and WapI proteins from Bacillus amyloliquefaciens, genes that encode the proteins, vectors that express the proteins, and cells constructed to express the proteins. Also disclosed are methods for introducing the vectors into cells, classifying WapA/WapI proteins into functional groups, and determining compatibility of strains expressing WapA/WapI proteins.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: November 5, 2019
    Assignee: NOVOZYMES BIOAG A/S
    Inventors: Barbara Cherry, Randy Berka
  • Publication number: 20190185847
    Abstract: The present invention relates to methods for improving at least one property of a microorganism host cell by repressing the expression of one or more genome target sequence of interest by CRISPR-inhibition as well as the resulting host cells and methods of production emplying said host cells.
    Type: Application
    Filed: July 5, 2017
    Publication date: June 20, 2019
    Applicant: Novozymes A/S
    Inventors: Michael Dolberg Rasmussen, Poul Erik Pedersen, Carsten Hjort, Barbara Cherry
  • Publication number: 20190024123
    Abstract: The present invention relates to methods for modifying the genome of a Bacillus host cell by employing a Class II Cas9 enzyme with only one active nuclease domain, e.g. the S. pyogenes Cas9 nickase, together with a suitable guide RNA for each target sequence to generate a site-specific nick in at least one genome target sequence followed by the repair of the nick(s) via integration of one or more modified modified donor part of the Bacillus host cell genome through classical double homologous recombination on each side of the nick(s).
    Type: Application
    Filed: January 6, 2017
    Publication date: January 24, 2019
    Applicant: Novozymes A/S
    Inventors: Randy Berka, Barbara Cherry
  • Publication number: 20180319851
    Abstract: Disclosed are WapA and WapI proteins from Bacillus amyloliquefaciens, genes that encode the proteins, vectors that express the proteins, and cells constructed to express the proteins. Also disclosed are methods for introducing the vectors into cells, classifying WapA/WapI proteins into functional groups, and determining compatibility of strains expressing WapA/WapI proteins.
    Type: Application
    Filed: November 11, 2016
    Publication date: November 8, 2018
    Applicant: NOVOZYMES BIOAG A/S
    Inventors: Barbara Cherry, Randy Berka
  • Publication number: 20160168547
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: February 23, 2016
    Publication date: June 16, 2016
    Applicants: Novozymes Inc., Novozymes A/S
    Inventors: Suzanne Otani, Debbie Yaver, Haiyan Ge, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Publication number: 20160115490
    Abstract: Provided herein are Bacillus mutants having improved transformation efficiency, comprising a disruption of an endogenous epsA-O operon. Also described are methods for producing the mutants, methods for generating transformants using the mutants, and methods for producing a polypeptide or fermentation product using the mutants.
    Type: Application
    Filed: June 18, 2014
    Publication date: April 28, 2016
    Applicant: Novozymes A/S
    Inventors: Barbara Cherry, Randy Berka
  • Patent number: 9303248
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 22, 2013
    Date of Patent: April 5, 2016
    Assignees: NOVOZYMES A/S, NOVOZYMES, INC.
    Inventors: Suzanne Otani, Debbie Yaver, Haiyan Ge, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Publication number: 20150218567
    Abstract: Provided herein are Bacillus mutants having improved transformation efficiency, comprising a disruption to an endogenous mecA gene and disruption to an endogenous sinI gene. Also described are methods for producing the mutants, methods for generating transformants using the mutants, and methods for producing a polypeptide or fermentation product using the mutants.
    Type: Application
    Filed: September 26, 2013
    Publication date: August 6, 2015
    Applicant: Novozymes A/S
    Inventors: Randy Berka, Barbara Cherry
  • Patent number: 8940502
    Abstract: The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first polynucleotide comprising a nucleic acid sequence encoding the polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor; and (b) isolat
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: January 27, 2015
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Debbie Yaver, Mads Eskelund Bjornvad, Barbara Cherry
  • Patent number: 8685738
    Abstract: The present invention relates to methods of obtaining genetic competence in non-competent Bacillus cells for their transformation with exogenous DNA.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: April 1, 2014
    Assignee: Novozymes, Inc.
    Inventors: Randy Berka, Michelle Maranta, Maria Tang, Barbara Cherry
  • Patent number: 8389283
    Abstract: The present invention relates to methods of obtaining genetic competence in non-competent Bacillus cells for their transformation with exogenous DNA.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: March 5, 2013
    Assignee: Novozymes, Inc.
    Inventors: Randy Berka, Michelle Maranta, Maria Tang, Barbara Cherry
  • Patent number: 8377675
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: January 29, 2010
    Date of Patent: February 19, 2013
    Assignee: Novozymes, Inc.
    Inventors: Suzanne Otani, Debbie Yaver, Haiyan Ge, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Publication number: 20130025005
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: August 30, 2012
    Publication date: January 24, 2013
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Debbie Yaver, Suzanne Otani, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Patent number: 8263824
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: April 5, 2012
    Date of Patent: September 11, 2012
    Assignees: Novozymes A/S, Novozymes, Inc.
    Inventors: Debbie Yaver, Suzanne Otani, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Publication number: 20120192316
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: April 5, 2012
    Publication date: July 26, 2012
    Applicants: Novozymes A/S, Novozymes, Inc.
    Inventors: Debbie Yaver, Suzanne Otani, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Patent number: 8158400
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Grant
    Filed: November 10, 2011
    Date of Patent: April 17, 2012
    Assignees: Novozymes, Inc., Novozymes A/S
    Inventors: Debbie Yaver, Suzanne Otani, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry
  • Publication number: 20120058930
    Abstract: The present invention relates to isolated polypeptides having lipase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.
    Type: Application
    Filed: November 10, 2011
    Publication date: March 8, 2012
    Applicants: NOVOZYMES A/S, NOVOZYMES, INC.
    Inventors: Debbie Yaver, Suzanne Otani, Janine Lin, Christopher Amolo, Kim Borch, Shamkant Anant Patkar, Michael Lamsa, Barbara Cherry